A class action lawsuit was filed against Medpace Holdings Inc. and senior executives alleging securities fraud. The suit follows significant stock declines linked to alleged violations of federal securities laws.
Latest development
Media Coverage · May 9, 2026
A class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and its senior executives for securities fraud. The lawsuit alleges that Medpace understated cancellation rates and overstated its book-to-bill ratio, leading to a significant stock drop. Investors who purchased Medpace stock are encouraged to seek additional information.
newspaper Read articleCourt
Court not identified
Awaiting court metadata
Docket
Not captured
Civil
Stage
Active litigation
Active
Filed
Date unavailable
Not in the available feed
Latest Filing
2026 - 05 - 09 | MEDP Deadline Notice : Medpace Securities Fraud Class Action on Behalf of Investors is Pending - Court
Media Coverage · May 09, 2026
Coverage
1 article
1 source tracked
Participants
3 Related Organizations
4 linked entities
Judge
Not assigned in feed
The court metadata has not been resolved yet, so Juryvine is keeping the page conservative until a reliable court match lands.
The newest docket activity we have is a media coverage dated May 09, 2026.
The visible party/entity graph currently includes Medpace Holdings Inc, National Law Journal and others.
Press monitoring has found 1 related article from 1 distinct source.
NEW YORK CITY, NY / ACCESS Newswire / May 9, 2026 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Medpace, you are encouraged to obtain additional information by visiting: Key Details of the Medpace ($MEDP
Open original open_in_newJuryvine summaries are generated from court records. Expand "Source" on any row to see the underlying filing.
A class action lawsuit has been filed against Medpace Holdings Inc. (NASDAQ:MEDP) and its senior executives for securities fraud. The lawsuit alleges that Medpace understated cancellation rates and overstated its book-to-bill ratio, leading to a significant stock drop. Investors who purchased Medpace stock are encouraged to seek additional information.
NEW YORK CITY, NY / ACCESS Newswire / May 9, 2026 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed …
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
14 hours, 24 minutes ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.